Works matching IS 1470269X AND DT 2012 AND VI 12 AND IP 1

Results: 10

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 1, p. 62, doi. 10.1038/tpj.2010.66

By:

Risselada, A J;
Vehof, J;
Bruggeman, R;
Wilffert, B;
Cohen, D;
Al Hadithy, A F;
Arends, J;
Mulder, H

Publication type:

Article

Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 1, p. 68, doi. 10.1038/tpj.2010.70

By:

Perroud, N;
Uher, R;
Ng, M Y M;
Guipponi, M;
Hauser, J;
Henigsberg, N;
Maier, W;
Mors, O;
Gennarelli, M;
Rietschel, M;
Souery, D;
Dernovsek, M Z;
Stamp, A S;
Lathrop, M;
Farmer, A;
Breen, G;
Aitchison, K J;
Lewis, C M;
Craig, I W;
McGuffin, P

Publication type:

Article

Genomics and pharmacogenomics of pancreatic adenocarcinoma.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 1, p. 1, doi. 10.1038/tpj.2011.52

By:

Lowery, M A;
O'Reilly, E M

Publication type:

Article

Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 1, p. 86, doi. 10.1038/tpj.2010.64

By:

Leventhal, A M;
David, S P;
Brightman, M;
Strong, D;
McGeary, J E;
Brown, R A;
Lloyd-Richardson, E E;
Munafò, M;
Uhl, G R;
Niaura, R

Publication type:

Article

The genetics of loop diuretic effects.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 1, p. 45, doi. 10.1038/tpj.2010.68

By:

Vormfelde, S V;
Brockmöller, J

Publication type:

Article

Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 1, p. 54, doi. 10.1038/tpj.2010.74

By:

Liou, Y-J;
Bai, Y M;
Lin, E;
Chen, J-Y;
Chen, T-T;
Hong, C-J;
Tsai, S-J

Publication type:

Article

A new mouse mutant of the Cdh23 gene with early-onset hearing loss facilitates evaluation of otoprotection drugs.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 1, p. 30, doi. 10.1038/tpj.2010.60

By:

Han, F;
Yu, H;
Tian, C;
Chen, H E;
Benedict-Alderfer, C;
Zheng, Y;
Wang, Q;
Han, X;
Zheng, Q Y

Publication type:

Article

Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 1, p. 10, doi. 10.1038/tpj.2010.67

By:

Miller, W R;
Larionov, A;
Anderson, T J;
Evans, D B;
Dixon, J M

Publication type:

Article

Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 1, p. 78, doi. 10.1038/tpj.2010.69

By:

Ji, Y;
Biernacka, J;
Snyder, K;
Drews, M;
Pelleymounter, L L;
Colby, C;
Wang, L;
Mrazek, D A;
Weinshilboum, R M

Publication type:

Article

Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT<sub>3</sub> antagonists tropisetron and ondansetron.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 1, p. 22, doi. 10.1038/tpj.2010.75

By:

Tzvetkov, M V;
Saadatmand, A R;
Bokelmann, K;
Meineke, I;
Kaiser, R;
Brockmöller, J

Publication type:

Article